PT  - JOURNAL ARTICLE
AU  - Lederman, Lynne
ED  - Sternberg, Cora N.
TI  - Optimized and New Therapies Will Improve Prognosis in Patients with Advanced Prostate Cancer
DP  - 2014 Aug 01
TA  - MD Conference Express
PG  - 24--26
VI  - 14
IP  - 14
4099  - http://mdc.sagepub.com/content/14/14/24.short
4100  - http://mdc.sagepub.com/content/14/14/24.full
AB  - The androgen receptor (AR) remains the most important target for metastatic castration-resistant prostate cancer (mCRPC). This article discusses new treatment modalities, including androgen synthesis inhibitors, chemotherapy, immunotherapy and radionuclide therapy.